Suppr超能文献

关于日本急诊医生对接受体外心肺复苏的院外心脏骤停患者进行高级机械循环支持升级治疗的认知调查。

Survey on Japanese emergency physicians' awareness of advanced mechanical circulatory support upgrade therapy for patients with out-of-hospital cardiac arrest receiving extracorporeal cardiopulmonary resuscitation.

作者信息

Hada Tasuku, Hifumi Toru, Isokawa Shutaro, Tsukamoto Yasumasa, Fukushima Norihide, Otani Norio

机构信息

Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.

Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

出版信息

J Artif Organs. 2025 Apr 14. doi: 10.1007/s10047-025-01502-1.

Abstract

Destination therapy (DT) using an implantable left ventricular assist device (i-LVAD) in Japan has expanded treatment options for patients with out-of-hospital cardiac arrest (OHCA) receiving extracorporeal cardiopulmonary resuscitation (ECPR). However, achieving hemodynamic stabilization and improved peripheral organ perfusion is essential. In patients with OHCA, percutaneous mechanical circulatory support (MCS) devices may be inadequate in some cases, necessitating surgical MCS. Despite the growing importance of MCS upgrading, awareness among Japanese emergency physicians remains unclear. We aimed to assess awareness of advanced MCS upgrading strategies in refractory patients after ECPR. A nationwide survey of 293 emergency and critical care centers in Japan assessed awareness of i-LVAD therapy after ECPR. The questionnaire collected data on demographics, LVAD strategy recognition, MCS upgrade practices, and barriers. Of 90 facilities (31%) that responded, 87 (30%) consented to using their responses in the analysis. Awareness of DT was 59.8%. Notably, 66.7% and 70.1% of the respondents recognized that MCS upgrading could lead to i-LVAD treatment and heart transplantation, respectively. The major barrier to MCS upgrade therapy was the facility's inability to implement it. DT awareness was similar between IMPELLA-registered and non-registered facilities, but i-LVAD indication recognition was higher in IMPELLA-registered facilities (78.0% vs. 51.4%, P = 0.009). The low survey response rate suggests limited MCS upgrade awareness among Japanese emergency physicians. Although facilities recognize pathways to i-LVAD and transplantation, barriers to their implementation persist. IMPELLA-registered facilities showed higher i-LVAD indication recognition, reflecting their accessibility to LV unloading devices and connections with backup hospitals.

摘要

在日本,使用植入式左心室辅助装置(i-LVAD)进行目标治疗(DT)为接受体外心肺复苏(ECPR)的院外心脏骤停(OHCA)患者扩展了治疗选择。然而,实现血流动力学稳定和改善外周器官灌注至关重要。在OHCA患者中,经皮机械循环支持(MCS)装置在某些情况下可能不足,需要进行外科MCS。尽管MCS升级的重要性日益增加,但日本急诊医生对此的认识仍不明确。我们旨在评估ECPR后难治性患者对高级MCS升级策略的认识。对日本293个急诊和重症监护中心进行的全国性调查评估了ECPR后i-LVAD治疗的认识。问卷收集了关于人口统计学、LVAD策略认知、MCS升级实践和障碍的数据。在90个做出回应的机构(31%)中,87个(30%)同意将其回复用于分析。DT的知晓率为59.8%。值得注意的是,分别有66.7%和70.1%的受访者认识到MCS升级可导致i-LVAD治疗和心脏移植。MCS升级治疗的主要障碍是机构无法实施。IMPELLA注册机构和未注册机构之间的DT知晓率相似,但IMPELLA注册机构对i-LVAD适应症的认知更高(78.0%对51.4%,P = 0.009)。调查回复率低表明日本急诊医生对MCS升级的认识有限。尽管各机构认识到通往i-LVAD和移植的途径,但其实施障碍仍然存在。IMPELLA注册机构对i-LVAD适应症的认知更高,这反映了它们更容易获得左心室卸载装置以及与后备医院的联系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验